Kuffcas Syrup
By Kuffcas
Rx
100ml Syrup in a Bottle

Composition
Ambroxol(15mg/5ml) + Guaifenesin(50mg/5ml) + Menthol(1mg/5ml) + Terbutaline(1.25mg/5ml)

Manufacturer - Medicasa Pharmaceutical
Plot No-464, Industrial Area Phase-1, Panchkula, 134113, Haryana, India

Expires on or after
October, 2025

liver
Kuffcas Syrup is considered safe for use by individuals with liver disease. From the available data, it appears that adjusting the dose of Kuffcas Syrup may not be necessary in such patients. However, it is always recommended to consult with your doctor before starting any medication, including Kuffcas Syrup, especially if you have liver issues. Consulting with your doctor will ensure that the medication is suitable for your specific condition and that it will not cause any harm to your liver.

kidney
Kuffcas Syrup is likely safe for patients with kidney disease, as per available data. Consult your doctor for guidance as dose adjustment may not be necessary.

alcohol
Consult your doctor when consuming alcohol with Kuffcas Syrup.

driving
When using Kuffcas Syrup, it is uncertain if it affects driving ability. Avoid driving if you have symptoms that impair focus and reaction time.

pregnancy
Kuffcas Syrup may not be safe to use during pregnancy. Animal studies suggest possible harm to the developing baby. Consult your doctor for a thorough evaluation of benefits and risks.

breastfeeding
It is better to consult your doctor before using Kuffcas Syrup during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹71
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024